
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RINT-1 CRISPR/Cas9 KO Plasmid (h) | sc-407428 | 20 µg | $397.00 |
RINT1 encodes RINT-1, a coiled-coil protein that contributes to Golgi and endoplasmic reticulum (ER) homeostasis by supporting vesicle tethering and membrane trafficking between these compartments. RINT-1 is implicated in maintaining proper secretory pathway organization and in coordinating cellular responses to proteotoxic and replication-associated stress, processes that intersect with genome stability and cell-cycle control. Disruption of RINT1-dependent trafficking can perturb protein processing and organelle integrity, leading to altered signaling and stress adaptation. Genetic and functional studies have linked RINT1 to cancer susceptibility and other proliferative disorders, making it relevant for investigating mechanisms that couple intracellular transport with oncogenic stress responses.
RINT-1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the RINT1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the RINT1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the RINT1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish RINT-1 protein expression.
This CRISPR knockout system enables efficient generation of RINT1-deficient cell models for investigation of RINT-1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.